Table 1.

Demographics, disease, and transplant characteristics

Variable	N (%) or median (range)
RIC (n = 19)	MAC (n = 19)	All (n = 38)
Sex
Female	8 (42)	11 (58)	19 (50)
Male	11 (58)	8 (42)	19 (50)
Race
White	12 (63)	12 (63)	24 (63)
Asian	4 (21)	4 (21)	8 (21)
Black	2 (11)	2 (11)	4 (11)
Unknown	1 (5)	1 (5)	2 (5)
Ethnicity
Hispanic	3 (16)	8 (42)	11 (29)
Non-Hispanic	15 (79)	11 (58)	26 (68)
Unknown	1 (5)	0 (0)	1 (3)
Patient’s age at HCT (y)	63 (33-72)	44 (21-57)	53 (21-72)
Primary disease
AML	5 (26)	12 (64)	17 (45)
ALL	3 (16)	5 (26)	8 (21)
MDS	5 (26)	1 (5)	6 (16)
NHL	3 (16)	0 (0)	3 (8)
CML	2 (11)	1 (5)	3 (8)
CLL	1 (5)	0 (0)	1 (2)
HCT comorbidity index	3 (0-6)	2 (0-6)	2 (0-6)
0	1 (5)	5 (26)	6 (16)
1-2	8 (42)	7 (37)	15 (39)
>2	10 (53)	7 (37)	17 (45)
DRI
Low	3 (16)	0 (0)	3 (8)
Intermediate	8 (42)	14 (74)	22 (58)
High	5 (26)	5 (26)	10 (26)
Very high	3 (16)	0 (0)	3 (8)
Sex donor/recipient
Female/male	4 (21)	0 (0)	4 (11)
Others	15 (79)	19 (100)	34 (89)
Donor age at HCT (y)	35 (24-53)	29 (19-48)	32 (19-53)
Patient CMV status
Negative	3 (16)	5 (26)	8 (21)
Positive	16 (84)	14 (74)	30 (79)
CD34+ dose (106 cells/kg)	5.28 (2.39-9.35)	6.28 (3.53-9.04)	5.45 (2.39-9.35)
Number of mismatches	3 (1-4)	2 (1-4)	2 (1-4)
HLA class I (A B C)
Matched	3 (16)	2 (11)	5 (13)
Mismatched (≥1)	16 (84)	17 (89)	33 (87)
HLA class II (DR DQ DP)
Matched	3 (16)	5 (26)	8 (21)
Mismatched (≥1)	16 (84)	14 (74)	30 (79)
HLA DQ
Matched	18 (95)	18 (95)	36 (95)
Mismatched (≥1)	1 (5)	1 (5)	2 (5)
HLA DP
Matched	4 (21)	6 (32)	10 (26)
Mismatched (≥1)	15 (79)	13 (68)	28 (74)